Retatrutide
Retatrutide
Purity>99.94%
The batch you'll receive
Batch: B-2026-RETA-60-002
Lab: Testides
Purity: >99.94%
Test date: 16.07.2026
View this batch's certificate of analysisFor research use only
This product is sold as a reagent for laboratory research and is not intended for administration to humans or animals.Delivery
International delivery: 7–21 days depending on the country. We confirm the cost after checkout. Kyiv delivery →
Payment
Cryptocurrency (USDT, BTC, ETH) or a Visa / Mastercard card (3-D Secure). Learn more →
Quality guarantee
Batches are independently lab-tested. For research use only.
Materials & documentation
Buying & pricing
About
Specifications
Q&A
What is the half-life of Retatrutide?
The half-life of retatrutide is approximately 6 days by subcutaneous administration, from the phase 1b study (Lancet). Retatrutide is investigational — no approved FDA/EMA label exists, so the half-life is known from clinical publications rather than a regulatory document. See the Dosing section for detail.
DosingDosing
Reference data — not a recommendation
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.Human studies evaluated several weekly target doses; no universal escalation schedule has been established.
Full dosing guideTitration schedule · reference
